A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis familial adenomatous polyposis

R. K.S. Phillips, M. H. Wallace, P. M. Lynch, E. Hawk, G. B. Gordon, B. P. Saunders, N. Wakabayashi, Y. Shen, S. Zimmerman, L. Godio, M. Rodrigues-Bigas, L. K. Su, J. Sherman, G. Kelloff, B. Levin, G. Steinbach, J. Abbruzzese, R. Dubois, T. Fujimura, W. HittlemanS. Jester, K. King, S. Patterson, M. Schumacher

Research output: Contribution to journal › Article › peer-review

391 Scopus citations

Fingerprint

Dive into the research topics of 'A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis familial adenomatous polyposis'. Together they form a unique fingerprint.

Medicine & Life Sciences